Afia Ali, PhD, UCL School of Pharmacy, University College London, London, UK, discusses new approaches to treating anxiety in patients with Alzheimer’s disease (AD). There is a great unmet need for specific treatments for anxiety in AD, as the standard drugs for non-AD anxiety are not well-suited to the treatment of these patients, and can have significant side effects. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.